Please use this identifier to cite or link to this item: https://ninho.inca.gov.br/jspui/handle/123456789/13664
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBrasil. Ministério da Saúde-
dc.contributor.authorInstituto Nacional de Câncer (Brasil)-
dc.contributor.authorInstituto Nacional de Câncer José Alencar Gomes da Silva-
dc.contributor.authorINCA-
dc.contributor.authorSistema Único de Saúde (Brasil)-
dc.date.accessioned2023-04-25T13:58:35Z-
dc.date.available2023-04-25T13:58:35Z-
dc.date.issued2023-02-
dc.identifier.urihttps://ninho.inca.gov.br/jspui/handle/123456789/13664-
dc.description1 p.pt_BR
dc.language.isoporpt_BR
dc.publisherINCApt_BR
dc.relation.ispartofseriesAno VII, n. 70.-
dc.subjectTerapêuticapt_BR
dc.subjectTherapeuticspt_BR
dc.subjectTerapéuticapt_BR
dc.titleSequência de linhas de tratamentopt_BR
dc.TypePeriodicalpt_BR
Appears in Collections:Informe SUS - ONCO 2023

Files in This Item:
File Description SizeFormat 
2_Fevereiro_2023.pdf441.61 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.